Mark Gustafson - Dec 14, 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Mark Gustafson
Stock symbol
ALZN
Transactions as of
Dec 14, 2021
Transactions value $
-$57,086
Form type
4
Date filed
12/16/2021, 04:00 PM
Previous filing
Oct 18, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale -$57.1K -20K -40% $2.85* 30K Dec 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price